Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

New Jersey Medical Aid in Dying Act Upheld on Appeal

By John Zen Jackson on July 19, 2022
Email this postTweet this postLike this postShare this post on LinkedIn

On June 10, 2022, the Appellate Division of the Superior Court of New Jersey filed an opinion in Petro v. Platkin, which has been approved for publication and thus will have precedential effect. The unanimous panel affirmed an Order entered by Judge Robert Lougy on April 1, 2020, dismissing the complaint challenging the validity of the New Jersey Medical Aid in Dying Act, often referred to by the acronym MAID, which authorizes a physician to prescribe medication to be self-administered by a patient for the purpose of ending the patient’s life. The trial court had ruled that the plaintiffs did not have standing to bring the challenge. The group of plaintiffs were composed of a terminally ill patient, a physician, and a pharmacist. Nonetheless, Judge Lougy addressed the merits of plaintiffs’ asserted unconstitutionality of the MAID on various grounds. He found them without merit.

In his opinion for the Appellate Division, Judge Natali agreed with the ruling as to lack of standing. He supported this conclusion with references to People ex rel. Becerra v. Superior Ct., and Lee v. Oregon, cases in which healthcare professionals lacked standing to challenge similar legislation in California and Oregon.

In addition, the court provided an “extensive amplification” of the lower court opinion “because of the significant issues raised related to the treatment of terminally ill patients as permitted under the Act.” The plaintiffs’ theory of the case asserted the following violations: (1) the New Jersey constitutional right to defend life; (2) equal protection; (3) the rights of health care providers under the Advance Directives Act; (4) the Free Exercise Clause of the United States Constitution; (5) the common law; (6) federal statutes regulating disposal of controlled substances; (7) the physician’s right to practice medicine (8) the duty to warn pursuant to N.J.S.A. 2A:62A-16; (9) the Administrative Procedure Act because of a total lack of agency regulation; (10) the Contracts Clause of the United States Constitution; and (11) the requirement to not falsify records.

The forty-four-page opinion reviews the legislative history and structure of the MAID and evaluates the various alleged constitutional and non-constitutional defects. It quickly but comprehensively rejected these claims. An important component of this analysis is an emphasis on the voluntary nature of participation in the MAID, whether by healthcare professional or patient.

This ruling is consistent with long-standing New Jersey law regarding an individual’s right to autonomy and privacy in the making of end-of-life decisions that can be traced back to In re Quinlan, a case later recognized by the Supreme Court of the United States as “seminal” in the development of this area of the law. The Legislature recognized that legacy in setting forth the intent and purpose of this law.

It would seem unlikely that the New Jersey Supreme Court will accept the case for further review, let alone reverse the outcome. It is uncertain how the current U.S. Supreme Court might react. The Quinlan rationale was initially based on a constitutional right of privacy although later supplemented with reliance on common law informed consent principles. In Dobbs v. Jackson Women’s Health Organization, the Supreme Court overturned Roe v. Wade. This decision potentially undermines the right of privacy, especially given comments in Justice Thomas’ concurring opinion, regardless of the disclaimers in Justice Alito’s opinion for the majority. This looming development casts assessment of the Petro case in a different light.

Photo of John Zen Jackson John Zen Jackson

Of Counsel, Healthcare and Litigation

John focuses his practice on civil litigation including trial and appellate advocacy, primarily in the healthcare area, as well as in healthcare regulatory and compliance matters. He has represented healthcare providers in the defense of professional liability claims…

Of Counsel, Healthcare and Litigation

John focuses his practice on civil litigation including trial and appellate advocacy, primarily in the healthcare area, as well as in healthcare regulatory and compliance matters. He has represented healthcare providers in the defense of professional liability claims, licensure and credentialing disputes, reimbursement disputes, insurance coverage and insurance fraud cases, qui tam actions under the Federal False Claims Act, and hospital privilege disputes including termination litigation. He has been responsible for matters involving medical staff privileges at the internal hearing level and in subsequent court litigation. He has additional experience as a hearing officer in hospital privilege disputes and in drafting medical staff bylaws. He has authoritative expertise in medical liability, biomedical ethics, and end-of-life issues.

Certified by the Supreme Court of New Jersey as a Civil Trial Attorney, John has litigated matters in judicial forums, trying numerous jury trials to verdict, and has appeared extensively before state administrative agencies and hospital credentialing committees. He has assisted healthcare entities seeking to outsource the handling of physician investigations, and physicians facing investigative inquiries and disciplinary charges before the Board of Medical Examiners (BME). He handles the full range of BME proceedings, including responding to an initial inquiry and appearing at a preliminary evaluation, responding to Orders to Show Cause and temporary suspension applications, hearings in the Office of Administrative Law (OAL), addressing the BME on disposition and discipline issues, argument of appeals before the Appellate Division, and appearances before the New Jersey Supreme Court.

Results may vary depending on your particular facts and legal circumstances.

Contact information:

jjackson@greenbaumlaw.com | 732.476.3336 | vCard

For more information visit the Greenbaum, Rowe, Smith & Davis LLP website.

Email
Show more Show less
  • Posted in:
    Health Care and Life Sciences
  • Blog:
    Healthcare Perspectives
  • Organization:
    Greenbaum, Rowe, Smith & Davis LLP
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo